The Academy met with the Center for Medicare & Medicaid Services and other physician and patient groups to ask the agency to reinstate a step therapy prohibition for Medicare Advantage plans for Part B drugs.
Member exclusive - Locked
Log in to keep reading.
Join AAO to get unlimited access to content. See member benefits or join today.